|
⚲
|
| Keyboard |
| AbbVie Inc | |
|---|---|
| Ticker | ABBV |
| CIK # | 0001551152 |
| CUSIP | 00287Y109 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1 North Waukegan Road, North Chicago, IL 60064 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| AbbVie Inc | 2016-05-09 | 3,800.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Over $100,000,000 |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001551152] | 10-K | |
| [0001551152] | 10-Q | |
| [0001551152] | 3 | |
| [0001551152] | 4 | |
| [0001551152] | 8-K | |
| [0001551152] | D | |
| [0001551152] | SC 13D | |
| [0001551152] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Vanguard Capital Management LLC | AbbVie Inc | [2026-04-29] | 0.0 |
| AbbVie Inc | Xilio Therapeutics Inc | [2025-02-18] | 0.0 |
| AbbVie Inc | Exicure Inc | [2017-10-06] | 5.5 |
| Capital Research Global Investors | AbbVie Inc | [2016-11-10] | 10.0 |
| AbbVie Inc | Reata Pharmaceuticals Inc | [2016-06-06] | 17.93 |
| Capital Research Global Investors | AbbVie Inc | [2014-02-13] | 6.3 |
| Vanguard Group Inc | AbbVie Inc | [2014-02-10] | 5.17 |
| AbbVie Inc | Enanta Pharmaceuticals Inc | [2014-02-07] | 5.97 |
| BlackRock Inc | AbbVie Inc | [2014-01-28] | 6.6 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Purdue David Ryan
Common Stock, $0.01 par value
|
2026-03-04 | Sell | 5,230 | $233.56 | 1,221,519 |
|
Siatis Perry C
Common Stock, $0.01 par value
|
2026-03-02 | Sell | 10,291 | $234.66 | 2,414,886 |
|
Siatis Perry C
Common Stock, $0.01 par value
|
2026-03-02 | Sell | 5,777 | $233.51 | 1,348,987 |
|
Siatis Perry C
Common Stock, $0.01 par value
|
2026-03-02 | Sell | 2,600 | $235.26 | 611,676 |
|
Saleki-Gerhardt Azita
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 16,309 | $232.08 | 3,784,993 |
|
Siatis Perry C
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 14,850 | $232.08 | 3,446,388 |
|
Stewart Jeffrey Ryan
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 23,812 | $232.08 | 5,526,289 |
|
Purdue David Ryan
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 2,692 | $232.08 | 624,759 |
|
Reents Scott T
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 21,638 | $232.08 | 5,021,747 |
|
Michael Robert A
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 36,523 | $232.08 | 8,476,258 |
|
Crum Demetris D
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 1,594 | $232.08 | 369,936 |
|
Donoghoe Nicholas
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 12,874 | $232.08 | 2,987,798 |
|
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 2,108 | $232.08 | 489,225 |
|
Thakkar Roopal
Common Stock, $0.01 par value
|
2026-02-27 | Tax withheld | 8,037 | $232.08 | 1,865,227 |
|
Siatis Perry C
Option (Right to buy) · derivative
|
2026-02-25 | Option exercise | 7,775 | $175.28 | 1,362,802 |
|
Siatis Perry C
Common Stock, $0.01 par value
|
2026-02-25 | Option exercise | 7,292 | $192.86 | 1,406,335 |
|
Siatis Perry C
Option (Right to buy) · derivative
|
2026-02-25 | Option exercise | 7,314 | $149.62 | 1,094,321 |
|
Siatis Perry C
Common Stock, $0.01 par value
|
2026-02-25 | Option exercise | 7,314 | $149.62 | 1,094,321 |
|
Siatis Perry C
Option (Right to buy) · derivative
|
2026-02-25 | Option exercise | 7,292 | $192.86 | 1,406,335 |
|
Siatis Perry C
Common Stock, $0.01 par value
|
2026-02-25 | Option exercise | 7,775 | $175.28 | 1,362,802 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 4,091 | 1,273,542,428 |
| 2025-12-31 | 4,160 | 1,306,991,365 |
| 2025-09-30 | 3,925 | 1,319,406,679 |
| 2025-06-30 | 3,753 | 1,284,312,017 |
| 2025-03-31 | 3,829 | 1,284,310,228 |
| 2024-12-31 | 3,748 | 1,275,638,332 |
| 2024-09-30 | 3,515 | 1,301,274,797 |
| 2024-06-30 | 3,382 | 1,294,495,454 |
| 2024-03-31 | 3,396 | 1,350,587,516 |
| 2023-12-31 | 3,333 | 1,314,159,809 |
| 2023-09-30 | 3,102 | 1,202,180,083 |
| 2023-06-30 | 3,085 | 1,191,433,604 |